Comprehensive Study Notes on Peripheral Venous Disorders and Pulmonary Embolism

Peripheral Arterial and Venous Disorders Overview

  • Peripheral Artery Disease (PAD): Focuses on arterial occlusion and aneurysms. Typical findings include:
    • Painful activity.
    • Cool extremities.
    • Pale skin.
    • Weak or absent pulses.
  • Venous Disorders: Involve impaired blood flow returning to the heart. When blood pools, pressure increases, and clot formation becomes a significant risk.
    • Examples: Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), and Varicose Veins.
    • Complications: A clot formed in a vein can travel through circulation and lodge in the lungs, creating a pulmonary embolism (PE), which is potentially life-threatening.
  • Lymphatic System: Responsible for removing fluids; impairment leads to increased infection risk and lymphedema.
    • Cellulitis: A bacterial infection of the skin and underlying tissue often associated with poor circulation. Symptoms include redness, warmth, swelling, and fever.

Peripheral Venous Disorders and Venous Thromboembolism (VTE)

  • Venous Thromboembolism (VTE): A broad term that includes:
    1. Deep Vein Thrombosis (DVT): The formation of a blood clot in a deep vein, most commonly in the leg.
    2. Pulmonary Embolism (PE): Occurs when part of that clot detaches and travels to the lungs.
  • Prevention Strategies: VTE is a major cause of preventable death in hospitalized patients. Prevention includes:
    • Early ambulation.
    • Frequent position changes.
    • Leg exercises.
    • Sequential Compression Devices (SCDs).
    • Anticoagulant therapy as prescribed.
  • Venous Insufficiency: Occurs when veins cannot effectively return blood. Findings include:
    • Leg edema.
    • Aching or heaviness.
    • Skin discoloration.
    • Venous stasis ulcers.
    • Management: Compression therapy, exercise, and elevating the legs.
  • Varicose Veins: Enlarged, twisted superficial veins caused by weakened walls. Symptoms include visible veins, leg discomfort, and fatigue. Management involves avoiding prolonged standing, weight management, and compression stockings.

Virchow’s Triad: The Mechanism of Clot Formation

  • Venous Stasis: Slower or pooling blood flow within the veins. Causes include:
    • Immobility or bed rest.
    • Prolonged travel.
    • Postoperative recovery.
    • Heart failure.
  • Endothelial Injury: Damage to the inner lining of the blood vessel, which activates the clotting process. Causes include:
    • Surgery.
    • Trauma.
    • IV catheter placement.
    • Inflammation.
  • Hypercoagulability: An increased tendency for blood to clot. Risk factors include:
    • Pregnancy.
    • Hormonal contraceptives (specifically those containing estrogen).
    • Cancer.
    • Smoking.
    • Genetic clotting disorders (e.g., Factor V Leiden deficiency).

Deep Vein Thrombosis (DVT) Assessment and Diagnosis

  • Locations: Approximately 80%80\% of cases occur in the deep or superficial veins of the calf and thigh. Upper extremity DVTs may occur due to peripherally inserted central catheters (PICC) or midlines.
  • Clinical Presentation: Often nonspecific and may be asymptomatic. Common findings include:
    • Unilateral leg swelling (edema in one leg, not both).
    • Pain, tenderness, or cramping in the calf.
    • Warmth and redness/discoloration of the affected extremity.
    • Induration (firm or hard tissue).
    • Increased calf circumference.
  • Laboratory Tests:
    • D-dimer: Measures fibrin degradation products. A value greater than 0.40.4 is typically considered positive. While it suggests clot breakdown, it is non-specific and can be elevated by surgery, pregnancy, or cancer.
    • Coagulation Studies: PT, aPTT, and INR are used to establish a baseline before therapy.
    • CBC: Assesses hydration (Hct), oxygen capacity (Hgb), and infection/inflammation (WBCs).
  • Diagnostic Imaging:
    • Venous Duplex Ultrasound: The preferred, first-line, non-invasive diagnostic tool for DVT. It uses sound waves to visualize blood flow and obstructions.
    • Doppler Flow Studies: Measures the audible sound of blood flow; decreased or absent sound suggests obstruction.
    • Venogram: An invasive procedure using contrast dye; used only if ultrasound results are unclear.

Pharmacological Management of DVT

  • Anticoagulants: These do not dissolve existing clots but prevent them from growing or new ones from forming.
  • Unfractionated Heparin:
    • Administered IV for acute DVT.
    • Requires monitoring of aPTT. Therapeutic range is typically 60−7060-70 seconds.
    • Complication: Heparin-induced thrombocytopenia (HIT), an immune response lowering platelets.
    • Antidote: Protamine sulfate.
  • Low Molecular Weight Heparin (LMWH) (e.g., Lovenox/Enoxaparin):
    • Given subcutaneously in the abdomen.
    • Do not expel the air bubble before injection.
    • More predictable response than standard heparin.
  • Warfarin (Coumadin):
    • Oral anticoagulant for long-term prevention.
    • Takes 3−43-4 days to reach therapeutic levels; requires "bridging therapy" with heparin initially.
    • Monitoring: PT and INR. Therapeutic INR is typically 2−32-3.
    • Antidote: Vitamin K.
    • Patient Education: Maintain consistent intake of Vitamin K-rich foods; avoid alcohol.
  • Factor Xa Inhibitors (e.g., Eliquis/Apixaban): Fixed dosing with no routine laboratory monitoring required.

Nursing Interventions for DVT and Prevention

  • Mobility: Encourage early ambulation once anticoagulation is initiated and deemed safe.
  • Exercises: Dorsiflexion and plantar flexion (ankle pumps) to activate calf muscles.
  • Positioning: Elevate legs to promote return; avoid placing pillows directly under the knees or excessive bending at the hips as this restricts flow.
  • Comfort: Apply intermittent or continuous warm, moist compresses.
  • Contraindications: NEVER massage the affected extremity, as it can dislodge the clot.
  • Hydration: Encourage adequate fluid intake to reduce blood viscosity.

Pulmonary Embolism (PE) Pathophysiology and Types

  • Definition: A medical emergency where a substance (embolus) blocks pulmonary blood vessels, obstructing blood flow and oxygen exchange.
  • Types of Emboli:
    • Blood Clot: Most common, resulting from DVT.
    • Fat Embolus: Associated with long bone fractures or orthopedic trauma.
    • Air Embolus: Can occur during central line insertion/removal or IV trauma.
    • Septic Embolus: Bacterial invasion of a thrombus.
    • Amniotic Fluid Embolus: Rare obstetric emergency during labor or delivery.
  • Age-Related Considerations: Older adults are at higher risk due to decreased pulmonary reserve, thickened alveolar walls, and reduced lung elasticity, making PEs more severe.

Pulmonary Embolism (PE) Clinical Assessment

  • Respiratory Symptoms:
    • Sudden onset of shortness of breath (dyspnea).
    • Pleuritic chest pain (sharp pain that worsens with breathing).
    • Tachypnea (rapid breathing).
    • Hemoptysis (coughing up blood).
    • Decreased oxygen saturation (SpO2SpO_2).
  • Cardiac/Systemic Symptoms:
    • Tachycardia and hypotension (indicating cardiovascular collapse).
    • Feeling of "impending doom" or severe anxiety.
    • Jugular Venous Distension (JVD) due to right heart strain.
    • Diaphoresis (sweating) and cyanosis (bluish skin).
    • Petechiae (small red/purple spots) over the chest or axilla.

Pulmonary Embolism (PE) Diagnosis and Medical Care

  • Primary Diagnostic Tool: Multi-detector Computed Tomography Angiography (MDCTA). It uses IV contrast to visualize the obstruction.
  • Ventilation-Perfusion (V/Q) Scan: Used if CT contrast is contraindicated.
  • ABG Analysis: Typically shows initial respiratory alkalosis (due to hyperventilation) followed by metabolic/respiratory acidosis as tissue hypoxia progresses.
  • Supportive Therapy:
    • High-flow oxygen or intubation.
    • IV fluids for hemodynamic support.
    • Meds: Dobutamine (cardiac output), Digitalis, Diuretics, and Morphine (to reduce anxiety and oxygen demand).
  • Surgical Interventions:
    • Surgical Embolectomy: Invasive removal of the clot.
    • Vena Cava Filter (IVC Filter): Traps future clots from the lower extremities before they reach the lungs; used when anticoagulants are contraindicated.
    • Thrombolytic Therapy: Specific "clot-busting" drugs used for life-threatening PEs. Note: Avoid all invasive procedures/injections after administration due to high bleeding risk.

Patient Education and Follow-Up

  • Bleeding Precautions: Use electric razors, soft toothbrushes, and avoid high-risk contact sports.
  • Symptom Reporting: Immediately report any blood in stool (red or black/tarry), blood in urine (reddish-brown), or bruising that continues to enlarge.
  • Procedure Safety: Inform dentists and surgeons of anticoagulant use; adjustments (like Vitamin K administration to lower INR) may be needed before surgery.
  • Lifestyle: Smoking cessation is critical to prevent vascular damage and abnormal clotting.